<--- Back to Details
First PageDocument Content
Flunixin / Norbrook / Organofluorides / Bioequivalence / Non-steroidal anti-inflammatory drug / Meglumine / Schering-Plough / Pharmacology / Pharmacokinetics / Pharmaceutical sciences
Flunixin
Norbrook
Organofluorides
Bioequivalence
Non-steroidal anti-inflammatory drug
Meglumine
Schering-Plough
Pharmacology
Pharmacokinetics
Pharmaceutical sciences

Date of Approval: October 14, 2014 FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA[removed]

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 106,69 KB

Share Document on Facebook

Similar Documents

FLUNIXIN - flunixin meglumine injection VetTek CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION Each milliliter of Flunixin Injectable Solution contains flunixin m

FLUNIXIN - flunixin meglumine injection VetTek CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION Each milliliter of Flunixin Injectable Solution contains flunixin m

DocID: 18FqD - View Document

Date of Approval: October 14, 2014  FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION  ANADA[removed]

Date of Approval: October 14, 2014 FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA[removed]

DocID: JS6f - View Document

Microsoft Word - Newsletter #4 clarification.doc

Microsoft Word - Newsletter #4 clarification.doc

DocID: CN9U - View Document

Microsoft Word[removed]387foi.doc

Microsoft Word[removed]387foi.doc

DocID: BicV - View Document

NADA[removed]Banamine® (flunixin meglumine) Injectable Solution

NADA[removed]Banamine® (flunixin meglumine) Injectable Solution

DocID: BcF5 - View Document